Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

SF 1751

as introduced - 89th Legislature (2015 - 2016) Posted on 03/17/2015 09:09am

KEY: stricken = removed, old language.
underscored = added, new language.

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8
1.9 1.10 1.11 1.12
1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 1.23 1.24
2.1 2.2 2.3 2.4 2.5 2.6 2.7
2.8 2.9 2.10 2.11 2.12 2.13
2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 2.32 2.33 2.34 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9

A bill for an act
relating to health; preserving effectiveness of antimicrobials used in the treatment
of disease or infection; prohibiting disposal of prescription drugs containing
antimicrobials; prohibiting use of medically important antimicrobials for
nontherapeutic use in animals; requiring reports; amending Minnesota Statutes
2014, sections 151.212, by adding a subdivision; 156.16, by adding a subdivision;
proposing coding for new law in Minnesota Statutes, chapters 115; 144; 156.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

new text begin [115.062] PROHIBITING DISPOSAL OF ANTIMICROBIAL
PRESCRIPTION DRUGS.
new text end

new text begin No person shall dispose of a prescription drug containing antimicrobials by
depositing the drug into a wastewater disposal system.
new text end

Sec. 2.

new text begin [144.9945] REPORTING ON PUBLIC HEALTH AND ANTIMICROBIAL
DRUG RESISTANCE.
new text end

new text begin The commissioner of health shall annually post to the department's Web site and
report to legislative committees with jurisdiction over health on:
new text end

new text begin (1) the number of antimicrobial-resistant infections in Minnesota and the number of
deaths from those infections, including the type and location of each occurrence;
new text end

new text begin (2) direct and indirect costs of treating antimicrobial-resistant infections in Minnesota;
new text end

new text begin (3) prevalence of antimicrobial-resistant E. coli, campylobacter, and salmonella
in retail meats;
new text end

new text begin (4) monitoring of antimicrobial-resistant bacteria, and antimicrobial residues in
drinking water supplies; and
new text end

new text begin (5) actions taken to preserve the effectiveness of medically important antimicrobials.
new text end

Sec. 3.

Minnesota Statutes 2014, section 151.212, is amended by adding a subdivision
to read:


new text begin Subd. 4. new text end

new text begin Disposal of prescription drugs containing antimicrobials. new text end

new text begin In addition to
the requirements of subdivisions 1 to 3, drugs dispensed containing an antimicrobial shall
bear a label affixed to the container in which the drug is dispensed and which is received
by the purchaser stating that it is unlawful to dispose of the drug by depositing it in a sink,
toilet, or any other wastewater disposal system.
new text end

Sec. 4.

Minnesota Statutes 2014, section 156.16, is amended by adding a subdivision
to read:


new text begin Subd. 5a. new text end

new text begin Medically important antimicrobial drug. new text end

new text begin "Medically important
antimicrobial drug" means an antimicrobial drug listed in Appendix A of the federal Food
and Drug Administration's Guidance for Industry No. 152, including critically important,
highly important, and important antimicrobial drugs, as that appendix may be amended.
new text end

Sec. 5.

new text begin [156.185] RESTRICTIONS ON USE OF MEDICALLY IMPORTANT
ANTIMICROBIAL DRUGS; USE REPORTING.
new text end

new text begin (a) After January 1, 2017, a medically important antimicrobial drug must not
be administered to an animal, unless prescribed by a veterinarian pursuant to a
veterinarian-client-patient relationship. Antimicrobial drugs may be prescribed for
animals only for:
new text end

new text begin (1) the treatment of disease or infection; or
new text end

new text begin (2) for prevention of disease or infection when the antimicrobial drug is used for a
short-term and medically appropriate duration in animals at high risk for disease to control
the spread of infections present in the same barn or equivalent housing unit.
new text end

new text begin (b) After January 1, 2017, a medically important antimicrobial drug must not be
administered to an animal for growth promotion, to cause an increased rate of weight
gain, or to improve feed efficiency.
new text end

new text begin (c) After January 1, 2017, a medically important antimicrobial drug must not be used
in hatcheries to inject into eggs hatching into chicks or poults being raised for food.
new text end

new text begin (d) Beginning January 1, 2017, a veterinarian who prescribes medically important
antimicrobial drugs must annually submit a report to the board for each prescription
including:
new text end

new text begin (1) the drug and drug class used;
new text end

new text begin (2) the dosage used;
new text end

new text begin (3) the species, the production class, and the number of animals treated;
new text end

new text begin (4) the number of days the drug was administered;
new text end

new text begin (5) the purpose for which the drug was administered, including whether for disease
treatment or disease prevention;
new text end

new text begin (6) the type of disease or infection that was treated; and
new text end

new text begin (7) the method by which the drug was administered, including oral, commercial
feed, water, or by injection.
new text end

new text begin (e) The board shall consult with the commissioner of health to ensure that reporting
under paragraph (d) can be readily integrated with the Department of Health tracking and
reporting of antimicrobial use and antimicrobial resistance in Minnesota.
new text end